 Janine Higgins
Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Intake | 18 | 2022 | 448 | 2.580 |
Why?
| | Starch | 5 | 2019 | 24 | 2.160 |
Why?
| | Dietary Carbohydrates | 8 | 2019 | 157 | 1.520 |
Why?
| | Weight Gain | 17 | 2022 | 493 | 1.300 |
Why?
| | Dietary Fats | 7 | 2019 | 325 | 1.260 |
Why?
| | Weight Loss | 14 | 2021 | 658 | 1.220 |
Why?
| | Energy Metabolism | 19 | 2021 | 767 | 1.160 |
Why?
| | Diet | 13 | 2024 | 1155 | 1.090 |
Why?
| | Insulin | 15 | 2020 | 2170 | 0.760 |
Why?
| | Postprandial Period | 5 | 2020 | 96 | 0.750 |
Why?
| | Mastication | 4 | 2024 | 14 | 0.720 |
Why?
| | Nutritive Value | 1 | 2019 | 29 | 0.710 |
Why?
| | Insulin Resistance | 11 | 2023 | 1184 | 0.650 |
Why?
| | Obesity | 19 | 2023 | 2751 | 0.630 |
Why?
| | Blood Glucose | 11 | 2023 | 1946 | 0.630 |
Why?
| | Sleep | 8 | 2022 | 660 | 0.620 |
Why?
| | Circadian Rhythm | 8 | 2022 | 401 | 0.570 |
Why?
| | Sleep Deprivation | 7 | 2021 | 164 | 0.560 |
Why?
| | Eating | 9 | 2021 | 369 | 0.560 |
Why?
| | Dietary Proteins | 4 | 2019 | 131 | 0.550 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2022 | 2179 | 0.520 |
Why?
| | Risk Reduction Behavior | 3 | 2020 | 199 | 0.480 |
Why?
| | Rats, Wistar | 16 | 2021 | 399 | 0.470 |
Why?
| | Lipogenesis | 2 | 2019 | 66 | 0.450 |
Why?
| | Triglycerides | 5 | 2019 | 521 | 0.440 |
Why?
| | Apolipoproteins B | 4 | 1999 | 44 | 0.440 |
Why?
| | Motor Activity | 2 | 2019 | 666 | 0.440 |
Why?
| | Physical Conditioning, Animal | 3 | 2019 | 204 | 0.430 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 74 | 0.420 |
Why?
| | Diet Records | 3 | 2022 | 81 | 0.420 |
Why?
| | Adipose Tissue | 5 | 2015 | 606 | 0.400 |
Why?
| | Wearable Electronic Devices | 2 | 2022 | 34 | 0.370 |
Why?
| | Vitamin D | 1 | 2013 | 354 | 0.350 |
Why?
| | Video Recording | 3 | 2019 | 156 | 0.350 |
Why?
| | Health Behavior | 2 | 2020 | 720 | 0.350 |
Why?
| | Glucose | 7 | 2023 | 954 | 0.350 |
Why?
| | Diet, Fat-Restricted | 5 | 2023 | 76 | 0.340 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 290 | 0.330 |
Why?
| | Rats | 17 | 2022 | 5394 | 0.320 |
Why?
| | Adipocytes | 4 | 2015 | 199 | 0.310 |
Why?
| | Work Schedule Tolerance | 2 | 2020 | 36 | 0.310 |
Why?
| | Feeding Behavior | 3 | 2019 | 601 | 0.310 |
Why?
| | Liver | 5 | 2019 | 1816 | 0.300 |
Why?
| | Lipoproteins, VLDL | 3 | 1999 | 20 | 0.300 |
Why?
| | Hypoglycemic Agents | 2 | 2011 | 1035 | 0.290 |
Why?
| | Amylose | 3 | 2003 | 4 | 0.280 |
Why?
| | Colorectal Neoplasms | 1 | 2013 | 628 | 0.280 |
Why?
| | Fish Oils | 4 | 2000 | 25 | 0.270 |
Why?
| | Family | 1 | 2009 | 587 | 0.270 |
Why?
| | Male | 36 | 2022 | 57818 | 0.260 |
Why?
| | Food | 1 | 2006 | 163 | 0.260 |
Why?
| | Caloric Restriction | 3 | 2019 | 91 | 0.260 |
Why?
| | Lithium | 1 | 2004 | 41 | 0.250 |
Why?
| | Metabolism | 1 | 2004 | 39 | 0.240 |
Why?
| | Cross-Over Studies | 3 | 2019 | 456 | 0.240 |
Why?
| | Hospitalization | 1 | 2013 | 1785 | 0.240 |
Why?
| | Intra-Abdominal Fat | 2 | 2019 | 98 | 0.240 |
Why?
| | Dietary Fiber | 1 | 2004 | 44 | 0.240 |
Why?
| | Health | 1 | 2004 | 81 | 0.240 |
Why?
| | Wakefulness | 3 | 2020 | 128 | 0.230 |
Why?
| | Humans | 41 | 2024 | 119032 | 0.230 |
Why?
| | Female | 26 | 2023 | 61588 | 0.230 |
Why?
| | Dietary Fats, Unsaturated | 3 | 2000 | 23 | 0.230 |
Why?
| | Overweight | 2 | 2018 | 502 | 0.210 |
Why?
| | Actigraphy | 1 | 2022 | 80 | 0.210 |
Why?
| | Cholesterol | 2 | 2019 | 375 | 0.210 |
Why?
| | Time Factors | 9 | 2022 | 6414 | 0.210 |
Why?
| | Animals | 27 | 2022 | 33399 | 0.210 |
Why?
| | Hot Temperature | 1 | 2003 | 334 | 0.200 |
Why?
| | Monitoring, Physiologic | 2 | 2024 | 272 | 0.200 |
Why?
| | Bone Remodeling | 1 | 2021 | 64 | 0.190 |
Why?
| | Lipoprotein Lipase | 1 | 2021 | 68 | 0.190 |
Why?
| | Patient Compliance | 1 | 2004 | 537 | 0.190 |
Why?
| | Oxidation-Reduction | 4 | 2019 | 940 | 0.190 |
Why?
| | Muscle, Skeletal | 6 | 2021 | 1523 | 0.190 |
Why?
| | Endoplasmic Reticulum, Rough | 2 | 1999 | 4 | 0.180 |
Why?
| | Intestines | 2 | 2014 | 332 | 0.180 |
Why?
| | Chylomicrons | 1 | 1999 | 7 | 0.180 |
Why?
| | Enterocytes | 1 | 1999 | 15 | 0.180 |
Why?
| | Double-Blind Method | 2 | 2019 | 1687 | 0.180 |
Why?
| | Diabetes, Gestational | 1 | 2023 | 284 | 0.170 |
Why?
| | Adolescent | 12 | 2022 | 18483 | 0.170 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 192 | 0.170 |
Why?
| | Body Fat Distribution | 1 | 2019 | 45 | 0.170 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 15 | 0.170 |
Why?
| | Oxygen Consumption | 2 | 2019 | 586 | 0.170 |
Why?
| | Hyperglycemia | 1 | 2022 | 316 | 0.170 |
Why?
| | Physical Exertion | 2 | 2011 | 222 | 0.170 |
Why?
| | Thermogenesis | 1 | 2019 | 43 | 0.170 |
Why?
| | Adaptation, Physiological | 4 | 2017 | 502 | 0.170 |
Why?
| | Healthy Volunteers | 1 | 2019 | 201 | 0.170 |
Why?
| | Subcutaneous Fat | 1 | 2019 | 82 | 0.170 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 97 | 0.170 |
Why?
| | Body Weight | 4 | 2017 | 934 | 0.170 |
Why?
| | Cold Temperature | 1 | 2019 | 132 | 0.160 |
Why?
| | Adult | 15 | 2022 | 31525 | 0.160 |
Why?
| | Nutrition Assessment | 1 | 2018 | 78 | 0.160 |
Why?
| | Kinetics | 4 | 2006 | 1625 | 0.150 |
Why?
| | Cortical Bone | 1 | 2017 | 18 | 0.150 |
Why?
| | Biomarkers | 4 | 2021 | 3590 | 0.150 |
Why?
| | Menopause | 1 | 2019 | 266 | 0.140 |
Why?
| | Ibuprofen | 1 | 2017 | 76 | 0.140 |
Why?
| | Metagenome | 2 | 2019 | 121 | 0.140 |
Why?
| | Body Composition | 3 | 2019 | 653 | 0.140 |
Why?
| | Bone Density | 1 | 2019 | 449 | 0.140 |
Why?
| | Ovary | 1 | 2017 | 205 | 0.130 |
Why?
| | Ovariectomy | 3 | 2022 | 124 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2011 | 3361 | 0.130 |
Why?
| | Breakfast | 1 | 2015 | 17 | 0.130 |
Why?
| | Osteogenesis | 1 | 2017 | 213 | 0.130 |
Why?
| | Child | 8 | 2022 | 19137 | 0.130 |
Why?
| | Models, Statistical | 1 | 2019 | 636 | 0.130 |
Why?
| | Adolescent Behavior | 1 | 2020 | 482 | 0.130 |
Why?
| | Glycogen | 3 | 2008 | 59 | 0.130 |
Why?
| | Sleep Stages | 1 | 2014 | 60 | 0.130 |
Why?
| | Deglutition | 1 | 2014 | 65 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 304 | 0.120 |
Why?
| | Fermentation | 1 | 2014 | 20 | 0.120 |
Why?
| | Satiation | 1 | 2014 | 24 | 0.120 |
Why?
| | Pantothenic Acid | 1 | 2013 | 4 | 0.120 |
Why?
| | Meals | 3 | 2022 | 101 | 0.120 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 26 | 0.110 |
Why?
| | Vitamin A | 1 | 2013 | 55 | 0.110 |
Why?
| | HIV-1 | 1 | 2019 | 776 | 0.110 |
Why?
| | Plant Oils | 4 | 2000 | 28 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 548 | 0.100 |
Why?
| | Recurrence | 4 | 2019 | 975 | 0.100 |
Why?
| | Adiposity | 4 | 2023 | 516 | 0.100 |
Why?
| | Melatonin | 3 | 2020 | 109 | 0.100 |
Why?
| | Fatty Acids, Volatile | 2 | 2019 | 47 | 0.100 |
Why?
| | Appetite Regulation | 1 | 2011 | 26 | 0.100 |
Why?
| | Exercise | 2 | 2018 | 1657 | 0.100 |
Why?
| | Random Allocation | 3 | 2023 | 349 | 0.100 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2015 | 167 | 0.100 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 162 | 0.100 |
Why?
| | Tritium | 2 | 2006 | 70 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2022 | 1965 | 0.090 |
Why?
| | Golgi Apparatus | 2 | 1998 | 91 | 0.090 |
Why?
| | Colorado | 1 | 2019 | 4196 | 0.090 |
Why?
| | Aging | 1 | 1999 | 1677 | 0.090 |
Why?
| | Self Report | 1 | 2013 | 699 | 0.090 |
Why?
| | Young Adult | 6 | 2022 | 10799 | 0.080 |
Why?
| | Mice | 4 | 2022 | 15528 | 0.080 |
Why?
| | Photography | 1 | 2009 | 93 | 0.080 |
Why?
| | Lipid Metabolism | 3 | 2011 | 477 | 0.080 |
Why?
| | Lipids | 3 | 2010 | 608 | 0.080 |
Why?
| | Disease Models, Animal | 7 | 2019 | 3730 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2874 | 0.070 |
Why?
| | Digestion | 1 | 2006 | 9 | 0.070 |
Why?
| | Phospholipids | 1 | 1988 | 208 | 0.070 |
Why?
| | Amylopectin | 2 | 1996 | 5 | 0.070 |
Why?
| | Microbiota | 1 | 2014 | 656 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2014 | 1295 | 0.070 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.060 |
Why?
| | Citrates | 1 | 2004 | 48 | 0.060 |
Why?
| | Satiety Response | 1 | 2004 | 8 | 0.060 |
Why?
| | HIV Infections | 1 | 2019 | 2461 | 0.060 |
Why?
| | Lipoproteins, LDL | 2 | 2001 | 138 | 0.060 |
Why?
| | Mental Processes | 1 | 2024 | 35 | 0.060 |
Why?
| | Radioimmunoassay | 1 | 2003 | 165 | 0.060 |
Why?
| | Sunflower Oil | 2 | 1999 | 5 | 0.060 |
Why?
| | C-Peptide | 1 | 2023 | 139 | 0.060 |
Why?
| | Fatty Acids | 2 | 2021 | 407 | 0.060 |
Why?
| | Rodentia | 1 | 2022 | 47 | 0.050 |
Why?
| | Tetrahydrofolates | 1 | 2001 | 11 | 0.050 |
Why?
| | Cohort Studies | 3 | 2020 | 5117 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 1947 | 0.050 |
Why?
| | Osteocalcin | 1 | 2021 | 35 | 0.050 |
Why?
| | Tumor Burden | 1 | 2022 | 275 | 0.050 |
Why?
| | Transcription Factors | 2 | 2019 | 1570 | 0.050 |
Why?
| | Rabbits | 2 | 1999 | 780 | 0.050 |
Why?
| | Collagen Type I | 1 | 2021 | 114 | 0.050 |
Why?
| | Postmenopause | 1 | 2022 | 306 | 0.050 |
Why?
| | Apolipoprotein B-48 | 1 | 1999 | 1 | 0.050 |
Why?
| | Cholesterol Esters | 1 | 1999 | 9 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Leptin | 2 | 2014 | 231 | 0.040 |
Why?
| | Apolipoprotein B-100 | 1 | 1999 | 8 | 0.040 |
Why?
| | Phenanthrolines | 1 | 1999 | 8 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 25 | 0.040 |
Why?
| | Leupeptins | 1 | 1999 | 10 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 1999 | 48 | 0.040 |
Why?
| | Polysomnography | 1 | 2020 | 157 | 0.040 |
Why?
| | Oleic Acid | 1 | 1999 | 34 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1999 | 86 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 1999 | 195 | 0.040 |
Why?
| | Tissue Distribution | 1 | 1999 | 334 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 121 | 0.040 |
Why?
| | Cricetinae | 1 | 1999 | 263 | 0.040 |
Why?
| | Receptors, LDL | 1 | 1998 | 40 | 0.040 |
Why?
| | Homeostasis | 2 | 2015 | 594 | 0.040 |
Why?
| | Fasting | 1 | 2020 | 264 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 2019 | 71 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 410 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 179 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 1999 | 125 | 0.040 |
Why?
| | Drug Combinations | 1 | 2019 | 291 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 1999 | 102 | 0.040 |
Why?
| | Calorimetry, Indirect | 2 | 2011 | 72 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 290 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 111 | 0.040 |
Why?
| | Models, Animal | 1 | 2019 | 363 | 0.040 |
Why?
| | Metagenomics | 1 | 2019 | 134 | 0.040 |
Why?
| | Glucose Tolerance Test | 2 | 1996 | 368 | 0.040 |
Why?
| | Dysbiosis | 1 | 2019 | 147 | 0.040 |
Why?
| | Running | 1 | 2019 | 227 | 0.040 |
Why?
| | Life Style | 1 | 2019 | 431 | 0.040 |
Why?
| | Regression Analysis | 1 | 1999 | 984 | 0.040 |
Why?
| | Feces | 1 | 2019 | 396 | 0.040 |
Why?
| | Absorption | 1 | 1996 | 56 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2019 | 355 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2013 | 12990 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1167 | 0.030 |
Why?
| | Deoxyglucose | 1 | 1996 | 46 | 0.030 |
Why?
| | Physical Fitness | 1 | 2017 | 179 | 0.030 |
Why?
| | Metformin | 1 | 2019 | 295 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2019 | 357 | 0.030 |
Why?
| | Peptide YY | 1 | 2014 | 10 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 1996 | 380 | 0.030 |
Why?
| | Hyperinsulinism | 1 | 1996 | 108 | 0.030 |
Why?
| | Body Mass Index | 2 | 2014 | 2092 | 0.030 |
Why?
| | Resistance Training | 1 | 2017 | 120 | 0.030 |
Why?
| | Ghrelin | 1 | 2014 | 30 | 0.030 |
Why?
| | Computational Biology | 1 | 2019 | 588 | 0.030 |
Why?
| | Microsomes | 2 | 1998 | 24 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 296 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1355 | 0.030 |
Why?
| | Risk Factors | 2 | 2020 | 9003 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1781 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2022 | 4596 | 0.030 |
Why?
| | Middle Aged | 4 | 2019 | 27627 | 0.030 |
Why?
| | Calorimetry | 1 | 2013 | 59 | 0.030 |
Why?
| | Gene Expression | 1 | 1998 | 1492 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2018 | 671 | 0.030 |
Why?
| | Electromyography | 1 | 2014 | 326 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2023 | 5256 | 0.030 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 241 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1346 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 5694 | 0.030 |
Why?
| | Age Factors | 1 | 2019 | 2995 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3173 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2661 | 0.020 |
Why?
| | Cells, Cultured | 1 | 1999 | 4081 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4552 | 0.020 |
Why?
| | Physical Examination | 1 | 2010 | 243 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2001 | 1802 | 0.020 |
Why?
| | Hormones | 1 | 2009 | 135 | 0.020 |
Why?
| | Immunosorbent Techniques | 1 | 1988 | 18 | 0.020 |
Why?
| | Palmitic Acids | 1 | 1988 | 9 | 0.020 |
Why?
| | Palmitic Acid | 1 | 1988 | 38 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 1988 | 74 | 0.020 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2008 | 38 | 0.020 |
Why?
| | Hyperplasia | 1 | 2008 | 170 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6562 | 0.020 |
Why?
| | Exercise Test | 1 | 2009 | 551 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 50 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 1988 | 241 | 0.020 |
Why?
| | Down-Regulation | 1 | 2008 | 627 | 0.020 |
Why?
| | United States | 1 | 2020 | 12557 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1634 | 0.010 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 229 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2446 | 0.010 |
Why?
| | Aged | 2 | 2019 | 19661 | 0.010 |
Why?
| | Homocysteine | 1 | 2001 | 137 | 0.010 |
Why?
| | Copper | 1 | 2001 | 102 | 0.010 |
Why?
| | Nutritional Physiological Phenomena | 1 | 1981 | 54 | 0.010 |
Why?
| | Catalysis | 1 | 2001 | 295 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2008 | 2275 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 938 | 0.010 |
Why?
| | Quality of Life | 1 | 2010 | 2369 | 0.010 |
Why?
| | Endoplasmic Reticulum, Smooth | 1 | 1998 | 4 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 84 | 0.010 |
Why?
| | Cytoplasmic Granules | 1 | 1998 | 84 | 0.010 |
Why?
| | Models, Biological | 1 | 2006 | 1715 | 0.010 |
Why?
| | Organ Specificity | 1 | 1996 | 278 | 0.010 |
Why?
| | Alcoholism | 1 | 1981 | 717 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2001 | 2275 | 0.010 |
Why?
| | Myocardium | 1 | 1996 | 970 | 0.010 |
Why?
| | Nutritional Requirements | 1 | 1981 | 75 | 0.000 |
Why?
| | Nitrogen | 1 | 1981 | 154 | 0.000 |
Why?
|
|
Higgins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|